Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution

Thrombosis Research

Volumn 96, Issue 6, 1999, Pages 451-458

  Birnbaum, Yochai ^a   Atar, Shaul ^b   Luo, Huai ^b   Nagai, Tomoo ^b   Siegel, Robert J ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Blood clot; Heparin; Microbubbles; Thrombolysis; Tirofiban; Tissue plasminogen activator; Ultrasound

Indexed keywords

FLUOROCARBON; FS 069; HEPARIN; SODIUM CHLORIDE; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOT LYSIS; CATHETER; CONTROLLED STUDY; DONOR; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; ULTRASOUND;

ALBUMINS; BLOOD COAGULATION; CONTRAST MEDIA; FIBRIN; FIBRINOLYTIC AGENTS; FLUOROCARBONS; HEPARIN; HUMANS; SODIUM CHLORIDE; SOLUBILITY; SONICATION; STENTS; THROMBOSIS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TYROSINE;

EID: 0032756675     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00139-5     Document Type: Article

References (32)

1. Topol E.J., Byzova T.V., Plow E.F. Platelet GPIIb-IIIa blockers. Lancet. 353:1999;227-231.
2. Braunwald E., Maseri A., Armstrong P.W., Califf R.M., Gilber W.B., Hamm C.W., Simooms M.G., Van de Werf F. Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes. Eur Heart J. 19(Suppl D):1998;D22-D30.
3. Sehgal C.M., Leveen R.F., Shlansky-Goldberg R.D. Ultrasound-assisted thrombolysis. Invest Radiol. 28:1993;939-943.
4. Harpaz D., Chen X., Francis C.W., Meltzer R.S. Ultrasound accelerates urokinase-induced thrombolysis and reperfusion. Am Heart J. 127:1994;1211-1219.
5. Kimura M., Iijima S., Kobayashi K., Furuhata H. Evaluation of the thrombolytic effect of tissue-type plasminogen activator with ultrasonic irradiation. In vitro experiment involving assay of the fibrin degradation products from the clot Biol Pharm Bull. 17:1994;126-130.
6. Olsson S.B., Johansson B., Nilsson A.M., Olsson C., Roijer A. Enhancement of thrombolysis by ultrasound. Ultrasound Med Biol. 20:1994;375-382.
7. Kornowski R., Meltzer R.S., Chernine A., Vered Z., Battler A. Does external ultrasound accelerate thrombolysis? Results from a rabbit model. Circulation. 89:1994;339-344.
8. Francis C.W., Blinc A., Lee S., Cox C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol. 21:1995;419-424.
9. Luo H., Nishioka T., Fishbein M.C., Cercek B., Forrester J.S., Kim C.J., Berglund H., Siegel R.J. Transcutaneous ultrasound augments lysis of arterial thrombi in vivo. Circulation. 94:1996;775-778.
10. Riggs P.N., Francis C.W., Bartos S.R., Penney D.P. Ultrasound enhancement of rabbit femoral artery thrombolysis. Cardiovasc Surg. 5:1997;201-207.
11. Akiyama M., Ishibashi T., Yamada T., Furuhata H. Low-frequency ultrasound penetrates the cranium and enhances thrombolysis in vitro. Neurosurgery. 43:1998;828-833.
12. Larsson J., Carlson J., Olsson S.B. Ultrasound enhanced thrombolysis in experimental retinal vein occlusion in the rabbit. Br J Ophthalmol. 82:1998;1438-1440.
13. Luo H., Birnbaum Y., Fishbein M.C., Peterson T.M., Nagai T., Nishioka T., Siegel R.J. Enhancement of thrombolysis in vivo without skin and soft tissue damage by transcutaneous ultrasound. Thromb Res. 89:1998;171-177.
14. Porter T, Li S, Siegel RJ, Deligonul U. Recanalization of acutely thrombosed carotid and coronary arteries with intravenous perfluorocarbon exposed sonicated dextrose microbubbles and transcutaneous low frequency ultrasound alone. Circulation 1998;98(Suppl I):I-503.
15. Atar S, Luo H, Nagai T, Sahm RA, McCreery T, Siegel RJ. In-vivo thrombolysis using a high-frequency intravascular transducer-tipped ultrasound catheter and local drug delivery in canine model. Circulation 1998;98(Suppl I): I-398.
16. Tachibana K., Tachibana S. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation. 92:1995;1148-1150.
17. Porter T.R., LeVeen R.F., Fox R., Kricsfeld A., Xie F. Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles. Am Heart J. 132:1996;964-968.
18. Nishioka T., Luo H.H.L., Fishbein M.C., Cercek B., Forrester J.S., Kim C.J., Berglund H., Siegel R.J. Dissolution of thrombotic arterial occlusion by high intensity low frequency ultrasound and dodecafluoropentane emulsion. In vitro and in vivo study Am Coll Cardiol. 30:1997;561-568.
19. Birnbaum Y., Luo H., Nagai T., Fishbein M.C., Peterson T.M., Li S., Kricsfeld D., Porter T.R., Siegel R.J. Noninvasive in vivo clot dissolution without a thrombolytic drug. Recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles Circulation. 97:1998;130-134.
20. Ferguson J.J., Lau T.K. New antiplatelet agents for acute coronary syndromes. Am Heart J. 135:1998;S194-S200.
21. Lincoff A.M. Trials of platelet GP IIb/IIIa receptor antagonists during percutaneous coronary revascularization. Am J Cardiol. 82:1998;36P-42P.
22. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med. 338:1998;1488-1497.
23. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. Circulation. 96:1997;1445-1453.
24. Kereiakes D.J., Kleiman N.S., Ambrose J., Cohen M., Rodriguez S., Palabrica T., Herrmann H.C., Sutton J.M., Weaver W.D., McKee D.B., Fitzpatrick V., Sax F.L. Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty. J Am Coll Cardiol. 27:1996;536-542.
25. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med. 338:1998;1498-1505.
26. Barrett J.S., Murphy G., Peerlinck K., DeLepeleine I., Gould R.J., Pamebianco D., Hand E., Deckmyn H., Vermylen J., Arnout J. Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men. Clin Pharmacol Ther. 56:1994;377-388.
27. Lynch J.J. Jr., Cook J.J., Sitko G.R., Holahan M.A., Ramjit D.R., Mellott M.J., Stranieri M.T., Stabilito I.I., Zhang G., Lynch R.J., Manno P.D., Chang C.T.-C., Egbertson M.S., Halczenko W., Duggan M.E., Laswell W.L., Vassallo L.M., Shafer J.A., Anderson P.S., Friedman P.A., Hartman G.D., Gould R.J. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383. J Pharmacol Exp Ther. 272:1995;20-32.
28. Nita H., Siegel R.J. Technical aspects of a therapeutic intravascular ultrasound angioplasty system. Siegel R.J. Ultrasound angioplasty. 1st ed:1996;229-240 Kluwer Academic Publishers, Norwell, MA.
29. Hamm C.W., Steffen W., Terres W., de Scheerder I., Reimers J., Cumberland D., Siegel R.J., Meinertz T. Intravascular therapeutic ultrasound thrombolysis in acute myocardial infarctions. Am J Cardiol. 80:1997;200-204.
30. Kong D.F., Califf R.M., Miller D.P., Moliterno D.J., White H.D., Harrington R.A., Tcheng J.E., Lincoff A.M., Hasselblad V., Topol E.J. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease. Circulation. 98:1998;2829-2835.
31. Chater B.V., Williams A.R. Platelet aggregation induced in vitro by therapeutic ultrasound. Thromb Haemost. 38:1977;640-651.
32. Williams A.R., Chater B.V., Allen K.A., Sherwood M.R., Sanderson J.H. Release of beta-thromboglobulin from human platelets by therapeutic intensities of ultrasound. Br J Haematol. 40:1978;133-142.